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ABSTRACT
Objective: The objective of this study was to
determine the attitudes and acceptability of self-
administered cervicovaginal sampling compared with
conventional physician-acquired Papanicolaou (Pap)
smear among multiethnic Malaysian women.
Method: A cross-sectional study was carried out via
interviewer-administered surveys from August 2013
through August 2015 at five government-run, urban
health clinics in the state of Selangor. Subjects were
participants from an ongoing community-based human
papillomavirus (HPV) prevalence study who answered
a standard questionnaire before and after self-
sampling. The cervicovaginal self-sampling for HPV
genotyping was performed using a simple brush (‘Just
for Me’; Preventive Oncology International, Hong
Kong). Detailed data on sociodemographics, previous
Pap smear experience, and attitudes towards self-
administered cervicovaginal sampling were collected
and analysed. Acceptability was inferred using a five-
item Likert scale that included six different subjective
descriptives: experience, difficulty, convenience,
embarrassment, discomfort or pain, and confidence in
collecting one’s own sample.
Results: Of the 839 participants, 47.9% were Malays,
followed by 30.8% Indians, 18.8% Chinese and 2.5%
from other ethnicities. The median age of the
participants was 38 years (IQR 30–48). Some 68.2%
of participants indicated a preference for self-sampling
over the Pap test, with 95% indicating willingness to
follow-up a positive result at the hospital. Age,
ethnicity and previous Pap test experience were
significant independent factors associated with
preference for self-sampling. The older the individual,
the less likely they were to prefer self-sampling
(adjusted OR 0.94, 95% CI 0.90 to 0.98). The Chinese
were less likely to prefer self-sampling (72.6%) than
the Malays (85.1%) (adjusted OR 0.57, 95% CI 0.33 to
0.98, p=0.004). Participants who had never undergone a
Pap smear were also more likely to prefer self-sampling
(88.5%) than women who had undergone a previous
Pap (80.9%) (adjusted OR 0.06, 95% CI 0.35 to 0.87).
Conclusions: Overall, urban Malaysian women from
multiethnic backgrounds found self-sampling to be an
acceptable alternative to Pap smear.
INTRODUCTION
Cervical cancer is the second most common
cancer among Malaysian women with an inci-
dence of over 16 per 100 000 and mortality
of over 8 per 100 000.1 2 While there is no
population-based cervical cancer screening
programme in Malaysia, the government has
supported opportunistic screening by provid-
ing free Pap smear tests since 1995. The
uptake of Papanicolaou (Pap) tests among
Malaysian women remains suboptimal, with
Strengths and limitations of this study
▪ This is one of the largest studies to systematic-
ally assess the acceptability of cervicovaginal
self-sampling as an alternative to Papanicolaou
(Pap) smear in a population with low screening
uptake.
▪ The study cohort consisted of a convenience
sample from healthcare clinics, possibly introdu-
cing bias, as it excluded those who may not
attend healthcare facilities for a variety of
reasons.
▪ This study could not assess and compare the
sensitivity and specificity of the screening
methods—that is, human papillomavirus geno-
typing versus Pap smear.
▪ The attitudes of those who declined to join the
study may have introduced bias to the results.
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less than half (47.3%) of the population having under-
gone one.3 Many reasons have been cited for the lack of
participation in cervical cancer screening, including
cost, embarrassment, fear, lack of knowledge and lack of
time.4–7 In 2010, the Malaysian government started a
national school-based human papillomavirus (HPV)
immunisation programme.8 Despite the success of the
national HPV vaccine programme, with more than 90%
of 13-year-old school girls being vaccinated,9 more com-
prehensive coverage and increased uptake of cervical
screening remains important for at least another 30–
40 years to adequately prevent the development of cer-
vical cancer in the Malaysian population.
In communities where uptake of conventional cervical
screening by cytology has been low, self-sampling may
offer an attractive alternative. Unlike Pap smear tests,
this procedure can be carried out by the individual
themselves without the help of a physician or medical
staff. This means that other logistical barriers involved
with Pap test screenings, such as long waiting times in
hospitals, inadequate number of and inexperienced
cytologists, and unequal distribution of healthcare
resources,10 can be overcome, making it a more efficient
and cost-effective option.11 12 There is a variety of self-
samplers available which allows different methods of
screening for cervical cancer. Generally, they are divided
into brush-based and lavage-based self-sampling devices
most commonly used for HPV genotyping but are also
suitable for cervical cytology and detection of biomar-
kers associated with cervical premalignant or malignant
diseases.13 14 Studies have shown a rise in participation
from non-respondents to screening programmes when
self-sampling methods are introduced.15–20 However,
owing to sociocultural and religious differences, it was
important to assess the value of self-sampling in a multi-
ethnic Asian community such as Malaysia. This study
aimed to explore the attitudes and perception before
and after the process of self-sampling for HPV genotyp-
ing to determine acceptability in comparison with the
Pap smear test among a multiethnic population.
METHOD
Participants
Volunteers for this cross-sectional study were recruited
via convenience sampling between August 2013 and
August 2015 from five government-run general practice
clinics (Klinik Kesihatan Pandamaran, Klinik Kesihatan
Ampang, Klinik Kesihatan Bandar Botani, Klinik
Kesihatan Batu 9, and University Malaya Medical
Centre), which are located in Selangor, the most devel-
oped state in Malaysia with a high level of urbanisation.
Subjects were participants from an ongoing community-
based HPV prevalence study (The Malaysian HPV
Prevalence Study), who were recruited during their visits
to the health clinics for primary care services, including
immunisation and routine health checks, and while
accompanying family members to these clinics.
Participants aged between 18 and 60 years old who
agreed to perform self-sampling joined this study. The
exclusion criteria were pregnancy, menstruation, acute
illness or never having been sexually active. This study
received approval from the Medical Research Ethics
Committee (NMRR-13-444-14609) and the University of
Malaya Medical Ethics Committee (MREC989.32).
Written informed consent was obtained from all partici-
pants. All patient responses were kept confidential.
Cervicovaginal self-sampling and assessment
Participants were invited to perform self-sampling on
their own using a simple brush (‘Just for Me’; courtesy
of Preventive Oncology International, Hong Kong). An
image of the brush can be seen in figure 1. Instructions
on how to use the self-sampler were given to the partici-
pants. Briefly, participants were instructed to gently push
the brush to the top of the vagina with one leg on a
chair. The brush is turned a few times to the left and
then the right before being removed completely. After
withdrawal, the brush is rubbed on to the Preventive
Oncology International FTA® card provided with the kit
and sealed in an envelope. The FTA® card is a solid
media specimen transport card and therefore eliminates
problems encountered with alcohol-based liquids, tem-
perature exposure and transportation difficulties.21
A questionnaire developed in a previous study22 was
modified and translated into Malay and Mandarin so it
could be applied to our multilingual population (see
online supplementary material file). It was administered
before and after the procedure. The preassessment was
intended to evaluate the initial response of the partici-
pants when they were introduced to the kit and later
compared with their actual experience, which was
recorded during the post-assessment. Acceptability
indices for the self-administered cervicovaginal sampling
included six items: experience, difficulty, convenience,
embarrassment, discomfort or pain, and confidence (as
shown in table 1). A five-item Likert scale was used in
the pre- and post-self-sampling questionnaire, where 5
was the most favourable response and 1 the most dis-
agreeable. A positive response towards self-sampling
(deemed as acceptable) was defined based on partici-
pant responses of 4 or 5 points using the Likert scale.
After self-sampling, we also inquired about participants’
preference for HPV testing: prefer self-sampling; no
preference (agreeable to both); prefer Pap testing.
Sociodemographic information was collected via
interviewer-administered questionnaire and included
information on age, ethnicity, highest attained educa-
tion, marital status, smoking status and previous Pap
testing experience.
Statistical analysis
Cronbach’s α coefficient which ranges from 0 to 1 was
used to ascertain internal consistency of the question-
naire. A low value shows poor reliability or consistency
among the items within the construct and a value of at
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least 0.7 is generally needed to show good reliability.
McNemar’s test was used for correlated proportions to
measure any significance in the change of acceptability
after self-sampling. Categorical variables were compared
using χ2. Continuous variables were described using
medians, as most of the variables were assumed to be
not normally distributed in the population, and com-
pared using the Mann-Whitney U test. Participants who
indicated that they preferred self-sampling as well as
those who did not have any preference (agreeable to
both methods) were categorised into ‘prefer self-
sampling’ and compared against participants who pre-
ferred the Pap test. Multivariable logistic regression ana-
lysis including age, highest attained education, ethnicity,
marital status, smoking status and previous Pap testing
experience was conducted to determine independent
predictors of preference for self-sampling. A p value of
<0.05 was considered to be significant. Data was analysed
using SPSS V.20.
RESULTS
Participant characteristics
A total of 839 women were interviewed and the median
age of the study participants was 38 years (IQR 30–48).
Most (82.7%) of the study population were premeno-
pausal, aged 50 years old and below. Malay women
represented the largest ethnic group (47.9%), followed
by Indians (30.8%), Chinese (18.8%) and other races
(2.5%), with 86.3% being married. Over half (57%) of
the participants were employed, while 35.2% were full-
time home-makers. Secondary education had been com-
pleted by 62.1%. Only 11.8% of women reported a
monthly household income of more than RM5000 (US
$1100). Out of the 839 women, 76% had heard of the
Pap smear before, with 63.1% having undergone a Pap
test. Most of the women (81.9%) who had undergone a
Pap smear test did so in the 5 years preceding the study.
Factors positively associated with previous experience
of Pap testing include higher education level (p<0.05),
Table 1 Indices of the five-item Likert scale for each of the categories
Likert scale 1 2 3 4 5
Experience Very bad Bad Neither Good Very good
Difficulty Very hard Hard Neither Easy Very easy
Convenience Very inconvenient Inconvenient Neither Convenient Very convenient
Embarrassment Very embarrassed Embarrassed Neither Not embarrassed Not embarrassed at all
Discomfort/pain Severe discomfort/pain Some discomfort/pain Neither No discomfort/pain No discomfort/pain at all
Confidence Not at all confident Unconfident Neither Confident Very confident
Figure 1 The ‘Just for Me’ self-administered cervicovaginal sampling brush, courtesy of Preventive Oncology International,
Hong Kong.
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older age (p<0.05) and higher income (p<0.05). Of the
women who had never undergone a Pap test, primary
barriers stated were lack of awareness (13%), lack of
time (10%), no existing symptoms (6.6%) and fear
(5.1%) (data not shown).
Self-administered cervicovaginal sampling is acceptable
Both pre- and post-questionnaires showed a high
internal consistency, with a Cronbach’s α value of 0.796
for the pre-questionnaire and 0.862 for the post-
questionnaire. In the pre-questionnaire, more than half
of the participants gave a positive response (score 4 or 5
on the Likert scale) for all six items tested: experience,
ease of procedure, convenience, embarrassment,
comfort and confidence. Table 2 shows the pre- and
post-test proportions of women who found self-sampling
acceptable (answered 4 or above on the Likert scale).
Most women’s perceptions changed significantly after
experiencing self-sampling in that, after self-sampling,
most reported the procedure to be easy (84.5%), con-
venient (86.3%) and not painful (78.2%) and expressed
confidence about collecting their own samples correctly
(79.6%).
Overall, the above findings indicate that there was an
increase in all six indices of acceptability after self-
sampling. In the post-questionnaire, it was also revealed
that the vast majority (91.8%) of the participants would
be willing to self-sample if it was made the only cervical
cancer screening option available. Most (95.2%) partici-
pants expressed willingness to go for a follow-up should
they obtain a positive result. Approximately two-thirds
(60.0%) preferred to carry out self-sampling at home,
and almost half (49.1%) would prefer to pick up the
self-sample kit at a nearby clinic.
Self-sampling versus conventional Pap test
After the procedure, 68.2% of the participants were
reported to have a preference for self-sampling com-
pared with 13.5% who preferred Pap smear tests, while
14.1% stated no preference (agreeable to both
methods). There were no significant differences in pref-
erence for self-sampling based on education level,
smoking and marital status (table 3). Women who pre-
ferred self-sampling were significantly younger than their
counterparts who preferred the Pap test. Ethnicity also
influenced preference for self-sampling, with the
Chinese less likely to prefer self-sampling than the Malays
(OR 0.57, 95% CI 0.33 to 0.98). For a sensitivity analysis,
the group of women were split into those who had and
had not previously undergone Pap tests. It was found that
prior experience of undergoing a Pap test had a signifi-
cant impact on the preference (p=0.01). Among the
women with no prior experience of Pap testing, self-
administered cervicovaginal sampling was preferred over
physician sampling in 75% of participants.
DISCUSSION
To our knowledge, this is one of the largest studies
where acceptability of self-sampling was systematically
assessed before and after the procedure was carried out
in a multiethnic Southeast Asian population. In this
study, 98% of the participants were within the screening
age population (21–65 years old), where 40% of the par-
ticipants had not undergone a Pap test in the past
3 years or more, and 36% of participants had never had
a Pap test. Cervical cancer, the second most prevalent
cancer among Malaysian women, is preventable, and an
estimated 70% of new cases can be prevented by screen-
ing and early detection.23 24 Unfortunately, the overall
uptake of the Pap smear in Asian countries, including
Malaysia, is still poor.4–7 25 Lack of awareness was the
main reason cited by the participants in this study for
never having undergone Pap smear tests before this.
This is also the most commonly cited reason in other
countries such as Turkey, Bangladesh, Gabon and
Korea.26–29 Therefore, increasing awareness of and edu-
cation about cervical cancer screening is necessary and
independent of the modality of screening. While self-
swabs and other self-sampling devices have been exam-
ined and reported to be reliable6 and not inferior to
specimens obtained by physicians,30 it is necessary to
investigate the perception and acceptability of self-
sampling among multiethnic Malaysian women, espe-
cially potential users who have never undergone Pap
testing.
Generally, participants found self-sampling to be
highly acceptable. Negative perceptions regarding the
use of self-sampling reported before experience with col-
lection decreased after having experienced the self-
collection first-hand. The acceptability scores indicated
Table 2 Percentage of women who found self-sampling acceptable (answered 4 or above on the Likert scale)
Pre-questionnaire, N (%) Post-questionnaire, N (%) p Value*
Good experience 588 (70.1) 686 (81.7) 0.004
Easy to do 570 (67.9) 709 (84.5) <0.001
Very convenient 647 (77.1) 724 (86.3) 0.021
Not embarrassing 716 (85.3) 740 (88.2) 0.267
No discomfort 426 (50.8) 656 (78.2) <0.001
Very confident 567 (67.6) 668 (79.6) 0.003
Overall median score 4.333 4.833
*Derived using McNemar’s test. p Values <0.05 were considered significant.
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that the participants were highly confident in collecting
their own samples. This is similar to studies undertaken
in Sub-Saharan Africa31 and Finland.19 Interestingly, in
studies where physician sampling was compared directly
with self-sampling, women trusted the physician sam-
pling more and had lower confidence in their own com-
petency.22 32 In our study, the level of education was
significantly associated with confidence, and, surpris-
ingly, those with a higher level of education were less
confident about self-collection. There could be several
explanations for this. It can be postulated that those
with a higher education tend to overthink and question
their abilities more. Education programmes designed to
show the validity of self-collection may help to alleviate
any concerns raised by doubtful participants. Another
reason could be that women with higher education were
more comfortable with a professional carrying out the
test rather than themselves. This is contradictory to
studies showing that education level did not have a sig-
nificant impact on self-sampling acceptability.33 The
majority (68.2%) of the women surveyed preferred self-
sampling compared with physician-sampled Pap smear
tests after carrying it out. This is not surprising, as issues
such as embarrassment and inconvenience could be
overcome with the use of self-samplers, enabling women
to do it independently in the comfort of their own
homes. These results are in line with those of previous
studies.22 34–38 However, prior experience with Pap
testing or the absence of any previous experience may
have influenced this decision. The results indicated that
physician sampling was less likely to be preferred than
self-administered cervicovaginal sampling for women
who have never undergone Pap testing. This result
matched a similar study25 in which patients with no
history of Pap testing were more inclined to self-
sampling. This finding has important implications, as
one of the target groups for improving cervical screen-
ing rates is non-attendees or those that have not partici-
pated in screening in any form.
It is worth noting that the different religions and cul-
tures among Malaysian women did not influence the
acceptability of self-sampling. This is in agreement with
previous findings,39 40 which also reported that cultural
or religious beliefs were not a barrier to screening par-
ticipation. Although in agreement with these findings,
Padela et al41 noted that there was a fatalistic attitude
related to negative religious coping, whereby individuals
felt that health issues were a penance from God, which
resulted in decreased willingness to undergo Pap testing.
Therefore, while religious beliefs did not appear to
influence acceptability of self-sampling, problems related
to fear of the diagnosis should still be addressed when
trying to implement self-administered cervicovaginal
sampling. In this study, self-sampling was found to be a
very acceptable tool even before it was carried out. The
results also suggest that age and ethnicity are important
predictors in this study to determine preference for self-
sampling. When planning a community-based model for
cervical cancer prevention, the involvement and proper
management by the local government administration
Table 3 Factors associated with preference for self-sampling
Participant characteristic Overall (N) Preferred self-sampling Preferred Pap test p Value* OR† 95% CI
Age 38 37 (30–47) 43 (31–52) 0.001‡ 0.98‡ 0.96 to 1.00
Education level
Basic 89 77 (86.5) 12 (13.5) 0.714 1.00§
Secondary 436 362 (83.0) 74 (17.0) 0.72 0.35 to 1.48
Tertiary and above 160 133 (83.1) 27 (16.9) 0.67 0.30 to 1.52
Ethnicity
Malay 335 285 (85.1) 50 (14.9) 0.004‡ 1.00§
Indian 213 183 (85.9) 30 (14.1) 1.09 0.65 to 1.83
Chinese 117 85 (72.6) 32 (27.4) 0.57‡ 0.33 to 0.98
Other 20 19 (95.0) 1 (5.0) 2.24 0.29 to 17.55
Marital status
Single 82 66 (80.5) 16 (19.5) 0.433 1.00§
Married 603 506 (83.9) 97 (16.1) 1.41 0.76 to 2.60
Smoking
Never 642 532 (82.9) 110 (17.1) 0.112 1.00§
Current or former 40 37 (92.5) 3 (7.5) 2.38 0.70 to 8.13
Previous Pap experience
Yes 434 351 (80.9) 83 (19.1) 0.010‡ 1.00§
No 243 215 (88.5) 28 (11.5) 1.46 0.88 to 2.41
Values are median (IQR) or N (%).
*χ2 test was used to compare categorical variables, whereas the Mann-Whitney test was used to compare age.
†OR for preference for self-sampling compared with preference for Pap testing, derived using a multivariable logistic regression model
mutually adjusted for age, highest attained education, ethnicity, marital status, smoking status and previous Pap test experience.
‡Results were considered to be significant, as the p value was <0.05, or 95% CI for OR did not include 1.00.
§Reference indicator.
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and community leaders is vital for its success. This was
exemplified in the work by 130 communities in China.42
A similar approach should be considered so that the
resources, planning and massive screening is carried out
efficiently and successfully in Malaysia.
Study strengths and limitations
One of the strengths of this study is its large sample size
and the diversity of the population surveyed in terms of
social and demographic characteristics. However, the
findings might not accurately represent the whole
Malaysian population because the participants mostly
consist of women in urban areas from a developed state
and not women in rural areas. Furthermore, the study
population was recruited from women who came to the
health centres, resulting in those unable to come
because of logistical barriers being missed. Thus, the
results represented women who had reasonable health-
care access. Despite this, nearly 40% had not previously
received a Pap test, indicating that access alone does not
completely explain the poor screening participation
rates in Malaysia. However, because of this design
feature, further studies are needed to assess the attitudes
of the rural Malaysian population towards self-
administered cervicovaginal sampling and its acceptabil-
ity, as this may represent one of the feasible alternatives
to broad screening in remote areas. It is possible even
with our findings in women who have access to health-
care and hospitals that others in rural areas might not
necessarily find self-sampling acceptable for different
reasons such as traditional mind sets or cultural taboos.
CONCLUSION
This study, which examined the acceptability of self-
administered cervicovaginal sampling among Malaysian
women, has shown encouraging results. Overall,
Malaysian women from different backgrounds found the
self-sampling method to be an acceptable alternative to
traditional Pap smears, hence increasing the options for
expanded cervical cancer prevention strategies in this
population.
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